Frontlight ResearchEarly access
Trial site
Stony Brook Cancer Center
- 10running trials
- 7closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Head and neck cancer3 trials
- Pancreatic cancer3 trials
- Acute myeloid leukaemia2 trials
- Neuroendocrine tumours2 trials
- Brain metastases1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Ovarian cancer1 trial
- Phase
- Phase 26 trials
- Phase 34 trials
- Phase 1/23 trials
- Phase 12 trials
- Early phase 11 trial
- Status
- Active, not recruiting5 trials
- Recruiting5 trials
- Completed4 trials
- Terminated3 trials
- Lead sponsor
- Bexion Pharmaceuticals, Inc.1 trial
- Biostar Pharma, Inc.1 trial
- Flamingo Therapeutics NV1 trial
- Genelux Corporation1 trial
- Gilead Sciences1 trial
- and 12 more
Running trials
Recruiting
Recruiting
Recruiting
Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia2 recruiting
- Brain metastases1 recruiting
- Lung cancer1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Terminated
Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC
Completed
Completed
Terminated
Completed
XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer
Terminated
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026